Table 1.
Characteristics of participants.
| Characteristics | Mean (95% CI)/N (%) | |
|---|---|---|
| Age | 48 (45.4–51.4) | |
| Sex | M | 12 (28.3) |
| F | 30 (71.4) | |
| Days after completing full dose of Verocell | 78.3 (73.9–82.8) | |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.